Literature DB >> 11516784

Microparticles for intranasal immunization.

M Vajdy1, D T O'Hagan.   

Abstract

Of the several routes available for mucosal immunization, the nasal route is particularly attractive because of ease of administration and the induction of potent immune responses, particularly in the respiratory and genitourinary tracts. However, adjuvants and delivery systems are required to enhance immune responses following nasal immunization. This review focuses on the use of microparticles as adjuvants and delivery systems for protein and DNA vaccines for nasal immunization. In particular we discuss our own work on poly(lactide co-glycolide) (PLG) microparticles with entrapped protein or adsorbed DNA as a vaccine delivery system. The possible mechanisms involved in the enhancement of immune responses through the use of DNA adsorbed onto PLG microparticles are also discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516784     DOI: 10.1016/s0169-409x(01)00167-3

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  12 in total

Review 1.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

2.  Mucosal vaccination against tuberculosis using inert bioparticles.

Authors:  Rajko Reljic; Laura Sibley; Jen-Min Huang; Ilaria Pepponi; Andreas Hoppe; Huynh A Hong; Simon M Cutting
Journal:  Infect Immun       Date:  2013-08-19       Impact factor: 3.441

3.  CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine.

Authors:  Hang Xie; Ihsan Gursel; Bruce E Ivins; Manmohan Singh; Derek T O'Hagan; Jeffrey B Ulmer; Dennis M Klinman
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 4.  Progress towards a needle-free hepatitis B vaccine.

Authors:  Filipa Lebre; Gerrit Borchard; Maria Conceição Pedroso de Lima; Olga Borges
Journal:  Pharm Res       Date:  2010-11-19       Impact factor: 4.200

5.  Preparation of polymeric submicron particle-containing microparticles using a 4-fluid nozzle spray drier.

Authors:  Tetsuya Ozeki; Shuji Beppu; Takuto Mizoe; Yuuki Takashima; Hiroshi Yuasa; Hiroaki Okada
Journal:  Pharm Res       Date:  2006-11-08       Impact factor: 4.200

6.  Evaluation of mucoadhesive PLGA microparticles for nasal immunization.

Authors:  Dilip Pawar; Amit K Goyal; Sharad Mangal; Neeraj Mishra; Bhuvaneshwar Vaidya; Shailja Tiwari; Arvind K Jain; Suresh P Vyas
Journal:  AAPS J       Date:  2010-01-15       Impact factor: 4.009

7.  Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.

Authors:  Michael Vajdy; Manmohan Singh; Mildred Ugozzoli; Maylene Briones; Elawati Soenawan; Lina Cuadra; Jina Kazzaz; Paolo Ruggiero; Samuele Peppoloni; Francesco Norelli; Giuseppe del Giudice; Derek O'Hagan
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

8.  CpG adjuvant enhances the mucosal immunogenicity and efficacy of a Treponema pallidum DNA vaccine in rabbits.

Authors:  Feijun Zhao; Shuangquan Liu; Xiaohong Zhang; Jian Yu; Tiebing Zeng; Weiming Gu; Xunyu Cao; Xi Chen; Yimou Wu
Journal:  Hum Vaccin Immunother       Date:  2013-04-01       Impact factor: 3.452

9.  Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid.

Authors:  Faezeh Moghadam Ariaee; Mohsen Tafaghodi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

10.  Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation.

Authors:  Liliana A Caetano; António J Almeida; Lídia M D Gonçalves
Journal:  Mar Drugs       Date:  2016-05-11       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.